March 2018
Features
How OCT angiography is improving our view of diabetic retinopathy
The data optical coherence tomography angiography obtains seem to correlate with the traditional clinical classification system of diabetic retinopathy.
Clinical Conversation Protocol U lessons for DME Management
Our expert panel explores insights about undertreatment and anatomical markers from the Phase II DRCRnet trial . Part 1 of 2.
Uveitis Update: the Paradigm Shifts Again
With new treatments on the verge of approval, here’s a timely review of management strategies.
Pipeline Update What’s Expected to Emerge in 2018
Here’s a look at no fewer than 19 agents for AMD and DME expected to reach important milestones in the next 12 months.
Departments
Clinical Trial Closeup
Moving the Needle on Ocular Cancer
How AU-011 selectively targets melanoma without damaging nearby ocular tissue.
Coding Commentary
I Just Bought an OCTA. Now What?
There’s already a CPT code for that. Here’s why it suffices to submit claims for optical coherence tomography angiography.
Editor's Page
Innovation Insight
Retina AI Platform Moves Forward
Autonomous artificial intelligence system aims to widen primary-care screening of diabetic retinopathy.
News
North of the Border
The Good and Bad of Retinal Fluid
The presence of intraretinal and subretinal fluid may answer the question: To treat or not to treat?
Retina Rounds
A Complicated, Recurrent RRD
How adding a scleral buckle corrected a complex proliferative vitreoretinopathy-related recurrent retinal detachment.
Surgical Pearl Video
Endoillumination Without an Assistant
A technique to perform peripheral vitreoretinal surgery with chandelier endoillumination independently.
Current Issue
Continuing Medical Education
Additional Publications
Learn More about Stargardt Disease
Watch the webinar
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
